• Published On : Oct-2018 |
  • Pages : 178 Pages |
  • Format :

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. PMR Analysis and Recommendations
     1.4. Wheel of Fortune

2. Market Introduction
     2.1. Market Definition
     2.2. Market Taxonomy

3. Sarcopenia Treatment Market Opportunity Analysis 
     3.1. Macro-Economic Factors
     3.2. Opportunity Analysis

4. Market Dynamics
     4.1. Drivers
     4.2. Restraints
     4.3. Trends

5. Key Inclusions
     5.1. Sarcopenia Treatment Market Pipeline Assessment
     5.2. Regulatory Guideline For Dietary Supplements

6. North America Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
     6.1. Introduction
     6.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
            6.2.1. U.S.
            6.2.2. Canada
     6.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
     6.4. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013–2017
            6.4.1. Protein Supplement
            6.4.2. Vitamin B12 Supplement
            6.4.3. Vitamin D & Calcium Supplement
     6.5. Market Size (US$ Mn) By Treatment Type, 2018–2026
     6.6. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
            6.6.1. Hospital Pharmacies
            6.6.2. Retail Pharmacies
            6.6.3. Online Pharmacies
            6.6.4. Hypermarket & Supermarket
     6.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     6.8. Market Attractiveness Analysis
            6.8.1. By Country
            6.8.2. By Treatment Type
            6.8.3. By Distribution Channel

7. Latin America Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
     7.1. Introduction
     7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
            7.2.1. Brazil
            7.2.2. Mexico
            7.2.3. Rest of Latin America
     7.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
     7.4. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013–2017
            7.4.1. Protein Supplement
            7.4.2. Vitamin B12 Supplement
            7.4.3. Vitamin D & Calcium Supplement
     7.5. Market Size (US$ Mn) By Treatment Type, 2018–2026
     7.6. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
            7.6.1. Hospital Pharmacies
            7.6.2. Retail Pharmacies
            7.6.3. Online Pharmacies
            7.6.4. Hypermarket & Supermarket
     7.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     7.8. Market Attractiveness Analysis
            7.8.1. By Country
            7.8.2. By Treatment Type
            7.8.3. By Distribution Channel

8. Europe Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
     8.1. Introduction
     8.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
            8.2.1. Germany
            8.2.2. U.K.
            8.2.3. France
            8.2.4. Italy
            8.2.5. Spain
            8.2.6. Russia
            8.2.7. Rest of Europe
     8.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
     8.4. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013–2017
            8.4.1. Protein Supplement
            8.4.2. Vitamin B12 Supplement
            8.4.3. Vitamin D & Calcium Supplement
     8.5. Market Size (US$ Mn) By Treatment Type, 2018–2026
     8.6. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
            8.6.1. Hospital Pharmacies
            8.6.2. Retail Pharmacies
            8.6.3. Online Pharmacies
            8.6.4. Hypermarket & Supermarket
     8.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     8.8. Market Attractiveness Analysis
            8.8.1. By Country
            8.8.2. By Treatment Type
            8.8.3. By Distribution Channel

9. Asia Pacific Excluding China Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
     9.1. Introduction
     9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
            9.2.1. Japan
            9.2.2. India
            9.2.3. China
            9.2.4. Australia and New Zealand
            9.2.5. Rest of Asia Pacific
     9.3. Market Size (US$ Mn) By Country, 2018–2026
     9.4. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013–2017
            9.4.1. Protein Supplement
            9.4.2. Vitamin B12 Supplement
            9.4.3. Vitamin D & Calcium Supplement
     9.5. Market Size (US$ Mn) By Treatment Type, 2018–2026
     9.6. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
            9.6.1. Hospital Pharmacies
            9.6.2. Retail Pharmacies
            9.6.3. Online Pharmacies
            9.6.4. Hypermarket & Supermarket
     9.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     9.8. Market Attractiveness Analysis
            9.8.1. By Country
            9.8.2. By Treatment Type
            9.8.3. By Distribution Channel

10. Middle East & Africa Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
     10.1. Introduction
     10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
            10.2.1. GCC Countries
            10.2.2. South Africa
            10.2.3. Rest of MEA
     10.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
     10.4. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013–2017
            10.4.1. Protein Supplement
            10.4.2. Vitamin B12 Supplement
            10.4.3. Vitamin D & Calcium Supplement
     10.5. Market Size (US$ Mn) By Treatment Type, 2018–2026
     10.6. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
            10.6.1. Hospital Pharmacies
            10.6.2. Retail Pharmacies
            10.6.3. Online Pharmacies
            10.6.4. Hypermarket & Supermarket
     10.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     10.8. Market Attractiveness Analysis
            10.8.1. By Country
            10.8.2. By Treatment Type
            10.8.3. By Distribution Channel

11. Forecast Assumptions

12. Driver Restraint Impact Analysis

13. Competition Analysis
     13.1. Competition Dashboard
     13.2. Company Deep Dive (Overview, Product Portfolio, Footprint, Strategy)
            13.2.1. Abbott Laborites
            13.2.2. Pfizer Inc.
            13.2.3. Novartis AG 
            13.2.4. GlaxoSmithKline Plc. 
            13.2.5. Nestlé S.A.
            13.2.6. Bayer AG
            13.2.7. Sanofi S.A.
            13.2.8. Amway
            13.2.9. Cadila Healthcare Ltd. 
            13.2.10. Eli Lilly and Company

14. Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026, By Region
     14.1. Introduction/Key Findings
     14.2. Historical Market Size (US$ Mn) Analysis By Region, 2013–2017
     14.3. Market Size (US$ Mn) Forecast By Region, 2018–2026
            14.3.1. North America
            14.3.2. Latin America
            14.3.3. Europe
            14.3.4. Asia Pacific
            14.3.5. Middle East & Africa
     14.4. Market Attractiveness Analysis By Region

15. Global Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026, By Treatment Type
     15.1. Introduction/Key Findings
     15.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013–2017
            15.2.1. Protein Supplement
            15.2.2. Vitamin B12 Supplement
            15.2.3. Vitamin D & Calcium Supplement
     15.3. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
     15.4. Market Attractiveness Analysis By Treatment Type

16. Global Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026, By Distribution Channel
     16.1. Introduction/Key Findings
     16.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
            16.2.1. Hospital Pharmacies
            16.2.2. Retail Pharmacies
            16.2.3. Online Pharmacies
            16.2.4. Hypermarket & Supermarket
     16.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     16.4. Market Attractiveness Analysis By Distribution Channel

17. Global Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
     17.1. Market Value Share Analysis By All Segment
     17.2. Y-o-Y Growth Analysis By All Segment
     17.3. Absolute $ Opportunity

18. Assumptions and Acronyms

19. Research Methodology


List of Table

Table 01: North America Sarcopenia Treatment Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 02: North America Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 03: North America Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 04: Latin America Sarcopenia Treatment Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 05: Latin America Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 06: Latin America Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 07: Europe Sarcopenia Treatment Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 08: Europe Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 09: Europe Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 10: Asia Pacific Sarcopenia Treatment Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 11: Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 12: Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 13: MEA Sarcopenia Treatment Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 14: MEA Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 15: MEA Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 16: Global Sarcopenia Treatment Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Region
Table 17: Global Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 18: Global Sarcopenia Treatment Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel


List of Figures

Figure 01: Global Sarcopenia Treatment Market Split By Treatment Type (2018)
Figure 02: Global Sarcopenia Treatment Market Split By Distribution Channel (2018)
Figure 03: Global Sarcopenia Treatment Market Split By Region (2018)
Figure 04: North America Sarcopenia Treatment Market Value Share By Treatment Type (2018)
Figure 05: North America Sarcopenia Treatment Market Value Share By Distribution Channel (2018)
Figure 06:  North America  Sarcopenia Treatment Market Value Share By Country (2018)
Figure 07: North America Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 08: North America Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 09 : U.S. Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 10: U.S. Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 11 : Canada Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 12: Canada Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 13: North America Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Protein Supplement
Figure 14: North America Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Protein Supplement
Figure 15: North America Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Vitamin B12 Supplement
Figure 16: North America Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Vitamin B12 Supplement
Figure 17: North America Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Vitamin D & Calcium Supplement
Figure 18: North America Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Vitamin D & Calcium Supplement
Figure 19: North America Sarcopenia Treatment Market Attractiveness Analysis, By Treatment Type
Figure 20: North America Sarcopenia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 21: North America Sarcopenia Treatment Market Attractiveness Analysis, By Country
Figure 22: Latin America Sarcopenia Treatment Market Value Share By Treatment Type (2018)
Figure 23: Latin America Sarcopenia Treatment Market Value Share By Distribution Channel (2018)
Figure 24:  Latin America  Sarcopenia Treatment Market Value Share By Country (2018)
Figure 25: Latin America Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 26: Latin America Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 27: Brazil Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 28: Brazil Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 29: Mexico Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 30: Mexico Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 31: Rest of Latin America Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 32: Rest of Latin America Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 33: Latin America Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Protein Supplement
Figure 34: Latin America Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Protein Supplement
Figure 35: Latin America Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Vitamin B12 Supplement
Figure 36: Latin America Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Vitamin B12 Supplement
Figure 37: Latin America Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Vitamin D & Calcium Supplement
Figure 38: Latin America Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Vitamin D & Calcium Supplement
Figure 39: Latin America Sarcopenia Treatment Market Attractiveness Analysis, By Treatment Type
Figure 40: Latin America Sarcopenia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 41: Latin America Sarcopenia Treatment Market Attractiveness Analysis, By Country
Figure 42: Europe Sarcopenia Treatment Market Value Share By Treatment Type (2018)
Figure 43: Europe Sarcopenia Treatment Market Value Share By Distribution Channel (2018)
Figure 44:  Europe  Sarcopenia Treatment Market Value Share By Country (2018)
Figure 45: Europe Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 46: Europe Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 47: Germany Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 48: Germany Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 49: U.K. Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 50: U.K. Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 51: France Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 52: France Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 53: Italy Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 54: Italy Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 55: Spain Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 56: Spain Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 57: Russia Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 58: Russia Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 59: Rest of Europe Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 60: Rest of Europe Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 61: Europe Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Protein Supplement
Figure 62: Europe Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Protein Supplement
Figure 63: Europe Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Vitamin B12 Supplement
Figure 64: Europe Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Vitamin B12 Supplement
Figure 65: Europe Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Vitamin D & Calcium Supplement
Figure 66: Europe Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Vitamin D & Calcium Supplement
Figure 67: Europe Sarcopenia Treatment Market Attractiveness Analysis, By Treatment Type
Figure 68: Europe Sarcopenia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 69: Europe Sarcopenia Treatment Market Attractiveness Analysis, By Country
Figure 70: Asia Pacific Sarcopenia Treatment Market Value Share By Treatment Type (2018)
Figure 71: Asia Pacific Sarcopenia Treatment Market Value Share By Distribution Channel (2018)
Figure 72:  Asia Pacific  Sarcopenia Treatment Market Value Share By Country (2018)
Figure 73: Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 74: Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 75: India Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 76: India Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 77: China Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 78: China Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 79: Australia and New Zealand Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 80: Australia and New Zealand Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 81: Japan Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 82: Japan Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 83: Rest of Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 84: Rest of Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 85: Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Protein Supplement
Figure 86: Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Protein Supplement
Figure 87: Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Vitamin B12 Supplement
Figure 88: Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Vitamin B12 Supplement
Figure 89: Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Vitamin D & Calcium Supplement
Figure 90: Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Vitamin D & Calcium Supplement
Figure 91: Asia Pacific Sarcopenia Treatment Market Attractiveness Analysis, By Treatment Type
Figure 92: Asia Pacific Sarcopenia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 93: Asia Pacific Sarcopenia Treatment Market Attractiveness Analysis, By Country
Figure 94: MEA Sarcopenia Treatment Market Value Share By Treatment Type (2018)
Figure 95: MEA Sarcopenia Treatment Market Value Share By Distribution Channel (2018)
Figure 96:  MEA  Sarcopenia Treatment Market Value Share By Country (2018)
Figure 97: MEA Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 98: MEA Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 99: South Africa Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 100: South Africa Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 101: GCC Countries Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 102: GCC Countries Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 103: Rest of MEA Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 104: Rest of MEA Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 105: MEA Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Protein Supplement
Figure 106: MEA Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Protein Supplement
Figure 107: MEA Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Vitamin B12 Supplement
Figure 108: MEA Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Vitamin B12 Supplement
Figure 109: MEA Sarcopenia Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Vitamin D & Calcium Supplement
Figure 110: MEA Sarcopenia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Vitamin D & Calcium Supplement
Figure 111: MEA Sarcopenia Treatment Market Attractiveness Analysis, By Treatment Type
Figure 112: MEA Sarcopenia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 113: MEA Sarcopenia Treatment Market Attractiveness Analysis, By Country
Figure 114: Global Sarcopenia Treatment Market Attractiveness Analysis, By Region
Figure 115: Global Sarcopenia Treatment Market Attractiveness Analysis, By Treatment Type
Figure 116: Global Sarcopenia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 117: Global Sarcopenia Treatment Market Value Analysis and Forecast, 2018–2026 (US$ Mn)
Figure 118: Global Sarcopenia Treatment Market  Absolute $ Opportunity (US$ Mn), 2013–2017
Figure 119: Global Sarcopenia Treatment Market  Absolute $ Opportunity (US$ Mn), 2018–2026